Determining the Viability a Lozenge Dosage for Probiotics | MicrobiomeTrials← Back to trialsNCT06819761
Determining the Viability a Lozenge Dosage for Probiotics
CompletedNAINTERVENTIONAL
Trial Details
Start: 2025-03-06Est. Completion: 2025-06-15
Enrollment target: 8 participants Locations- Ostia Sciences Inc, Toronto, Ontario, Canada
Other microbiome trials you might be interested in
Acute Ischemic Stroke
Acute ischemic stroke (AIS) is responsible for considerable morbidity and mortality worldwide and has serious medico-eco…
Tours, FranceCompleted Dec 10, 2025
DysphagiaEosinophilic Esophagitis
Background:
Eosinophilic esophagitis (EoE) is a disease that causes inflammation in the esophagus. The esophagus is the…
Bethesda, United StatesEst. completion Aug 31, 2027
Background:
The immune system helps the body fight infections. Primary immunodeficiency disorders (PIDs) are diseases t…
Bethesda, United StatesEst. completion Mar 31, 2038